SureTrader
Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

IMUC RSS Feed
Add IMUC Price Alert      Hide Sticky   Hide Intro
Moderator: hotrod34racer
Search This Board: 
Last Post: 2/23/2018 4:21:16 PM - Followers: 196 - Board type: Free - Posts Today: 0

 


 

 

ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.





Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

Potency
- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

Versatility
- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

Efficiency
- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

Cost-effectiveness
- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

Convenience
- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.


Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907

http://www.imuc.com 

-
Management:
  
http://imuc.com/team/

Technologies:   http://imuc.com/technology/

Press Releases:   http://imuc.com/press/

http://finance.yahoo.com/q/h?s=IMUC+Headlines
 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0000822411&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 -

Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300
Email: IR@imuc.com




 

 PIPELINE 







http://www.imuc.com/pipeline/ict-107/ict-107-faq

http://www.imuc.com/pipeline/ict-121

http://www.imuc.com/pipeline/ict-140



 UPDATE 



ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015
.   


>>> What these CANCER vaccines could be worth
 

 NEW  


Investor Presentation -> http://files.shareholder.com/downloads/AMDA-1HS8HT/61684022x0x652321/5FD13B20-8F93-44CE-994E-D5515E5F30FC/IMI_Corporate_Overview.pdf 



 

 

 

 

SureTrader
IMUC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
IMUC News: ImmunoCellular Therapeutics Announces Review of Strategic Alternatives 02/22/2018 06:00:00 AM
IMUC News: Amended Statement of Ownership (sc 13g/a) 02/13/2018 06:33:07 AM
IMUC News: Current Report Filing (8-k) 02/13/2018 06:32:40 AM
IMUC News: ImmunoCellular Therapeutics Announces Update on Financial Condition 02/13/2018 06:00:00 AM
IMUC News: Current Report Filing (8-k) 02/02/2018 04:19:43 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5138   investorshub.advfn.com/uimage/uploads/2018/2/23/qdtjpsc_(7).png Nyk1 02/23/18 04:21:16 PM
#5137   Long here and waiting patiently (kind of).. MTNBIRD 02/23/18 02:06:44 PM
#5136   $IMUC folks are sleeping on this one. A Nyk1 02/23/18 01:28:42 PM
#5135   investorshub.advfn.com/uimage/uploads/2018/2/23/vozrhsc.png Nyk1 02/23/18 03:20:42 AM
#5134   Early alert on IMUC. Setting up for massive OTC_MILLIONAIR 02/23/18 12:02:14 AM
#5133   $IMUC - s’go!!! Nyk1 02/22/18 01:33:53 PM
#5132   $IMUC - Potential Breakout Nyk1 02/22/18 09:36:46 AM
#5131   $IMUC - ImmunoCellular Therapeutics, Ltd. (IMUC) stock is Nyk1 02/22/18 07:10:20 AM
#5130   IMUC $$ tyguy1505 02/22/18 06:51:41 AM
#5129   $IMUC has a Return On Equity of 3756.93%. Nyk1 02/22/18 06:33:07 AM
#5128   ImmunoCellular Therapeutics Announces Review of Strategic Alternatives... Nyk1 02/22/18 06:16:11 AM
#5127   Here we go... Nyk1 02/22/18 05:42:34 AM
#5126   Finally moving! jade77 02/21/18 02:57:09 PM
#5125   $IMUC Nyk1 02/20/18 01:15:10 PM
#5124   investorshub.advfn.com/uimage/uploads/2018/2/15/skqmwsc_(2).png Nyk1 02/15/18 04:37:35 PM
#5123   Tomorrow is going to be a green day ... Nyk1 02/15/18 04:20:44 PM
#5122   I hope we move higher tomorrow. Thanks jade77 02/15/18 04:18:17 PM
#5121   Close GAP... Nyk1 02/15/18 03:55:45 PM
#5120   HEDGE FUNDS ACTIVITY IN IMMUNOCELLULAR THERAPEUTICS, LTD. (IMUC) Nyk1 02/15/18 05:19:15 AM
#5119   Are ImmunoCellular Therapeutics, Ltd. (IMUC)’s Recent Ownership and Nyk1 02/15/18 05:17:49 AM
#5118   This could take a long time IMO hotrod34racer 02/14/18 05:29:00 PM
#5117   Kind of a smash close there! hotrod34racer 02/14/18 04:37:08 PM
#5116   $IMUC this is going to be huge... Nyk1 02/14/18 04:18:34 PM
#5115   $IMUC .25 Break coming... Nyk1 02/14/18 03:48:59 PM
#5114   Go click on add me as mod, I hotrod34racer 02/14/18 02:07:32 PM
#5113   I think we first have to come to. Nyk1 02/14/18 10:27:00 AM
#5112   I’m in at .2450 jade77 02/14/18 10:22:42 AM
#5111   $IMUC -https://www.prnewswire.com/news-releases/immunocellular-therapeutics-anno Nyk1 02/14/18 05:59:41 AM
#5110   $IMUC - https://reurope.com/2018/02/13/immunocellular-therapeutics-ltd-intracoastal-capital-makes-pu Nyk1 02/14/18 05:14:13 AM
#5109   $IMUC - The 2 analysts offering 12-month price Nyk1 02/14/18 04:35:04 AM
#5108   It's good to have your here to help Nyk1 02/14/18 04:02:19 AM
#5107   These 3 Pharmaceutical Companies Control Roughly Half of hotrod34racer 02/13/18 07:57:44 PM
#5106   Not that I find your PUMP here annoying hotrod34racer 02/13/18 06:09:13 PM
#5105   * * $IMUC Video Chart 02-13-18 * * ClayTrader 02/13/18 05:05:48 PM
#5104   investorshub.advfn.com/uimage/uploads/2018/2/13/clgrwFOGUETE.jpg Nyk1 02/13/18 04:23:35 PM
#5103   investorshub.advfn.com/uimage/uploads/2018/2/13/hbxtbsc.png Nyk1 02/13/18 04:19:26 PM
#5102   Tomorrow .35$$$ +++ 1$ might come faster then Nyk1 02/13/18 01:54:11 PM
#5101   Nice cash! Joecanada13 02/13/18 01:11:50 PM
#5100   $IMUC partnership announcement will send this to at Nyk1 02/13/18 12:38:17 PM
#5099   WEEEEE!!!! PyschoNoobStock 02/13/18 12:32:17 PM
#5098   agreed $treet $inatra 02/13/18 12:30:50 PM
#5097   $IMUC One day this thing is gonna run Nyk1 02/13/18 12:29:36 PM
#5096   nice pattern... Nyk1 02/13/18 12:28:58 PM
#5095   has to fill that gap @ .80 someday https://stockcharts.com/c-sc/sc?s=IMUC&p $treet $inatra 02/13/18 12:23:00 PM
#5094   BAM!!! PyschoNoobStock 02/13/18 09:47:18 AM
#5093   Yeah monster sindram 02/13/18 08:15:09 AM
#5092   $1 coming... Nyk1 02/13/18 08:00:21 AM
#5091   $IMUC Great News, Cash flow positive, seeking “strategic Nyk1 02/13/18 07:50:56 AM
#5090   $IMUC - Successfully packaging T cell receptor DNA Nyk1 02/13/18 07:36:37 AM
#5089   SC-13G-a Nyk1 02/13/18 07:29:37 AM
PostSubject